Swimmingdancer
Bluelight Crew
From the Opana website:
http://www.opana.com/Supply Shortage and Rare Tablet Mix-up
Production of certain products has been temporarily suspended by our contract manufacturer in order for the manufacturer to implement manufacturing process improvements. These improvements are intended to address rare instances of errors in the packaging of the tablets, potentially resulting in product mix-ups. As a result of the implementation of these improvements, we anticipate that there may be a short-term disruption in the supply of these products to patients. This temporary supply disruption is not related to the efficacy or safety of these products.
Endo’s primary concerns are the health, well-being, and continuity of care for patients suffering from pain.
For patients currently prescribed any of the following products, a visual guide has been provided to verify the appearance of these products. Please review the product name of your prescription to confirm the tablets in your prescription match the tablet images provided:
OPANA® ER (oxymorphone hydrochloride)
Extended-Release Tablets CII
OPANA® (oxymorphone hydrochloride)
Tablets CII
Oxymorphone Hydrochloride Tablets CII
PERCOCET® (oxycodone hydrochloride and
acetaminophen USP) Tablets CII
PERCODAN® (oxycodone hydrochloride and
aspirin, USP) Tablets CII
ENDOCET® (oxycodone hydrochloride and
acetaminophen USP) Tablets CII
ENDODAN® (oxycodone hydrochloride and
aspirin, USP) Tablets CII
Morphine Sulfate Extended-Release
Tablets CII
ZYDONE® (hydrocodone
bitartrate/acetaminophen tablets, USP) CIII
